SHZ · 300298.SZ
Sinocare Inc.
CN¥18.01-CN¥0.12 (-0.66%)
Sinocare Inc.’s quoted price sits in the upper half of its reported 52-week range, 11.37% below the high.
Loading market information…
SHH · 603108.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Shanghai Runda Medical Technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 55.9% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Shanghai Runda Medical Technology Co., Ltd.’s forward annual dividend is CN¥0.03 per share, paid annual. The forward yield is 0.33% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Shanghai Runda Medical Technology Co., Ltd.’s next earnings report is currently expected on Oct 30, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Shanghai Runda Medical Technology Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Shanghai Runda Medical Technology Co., Ltd. delivers a comprehensive array of integrated medical laboratory solutions throughout China. The company's extensive offerings cover vital operational aspects for laboratories, including the provision of essential platforms, expert design and refurbishment services for facilities, the establishment of standardization protocols, and the implementation of advanced information management systems. Furthermore, Shanghai Runda supports healthcare professionals by providing medical solutions for critical diagnostic fields such as biochemistry, diabetes, Point-of-Care Testing (POCT), immunoassay analysis, and molecular biology. Alongside these, they also furnish professional technical assistance and efficient logistical services. Established in 1999, the firm is headquartered in Shanghai, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:27 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| CN¥2.04B-6.29% vs estimate |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥18.01-CN¥0.12 (-0.66%)
Sinocare Inc.’s quoted price sits in the upper half of its reported 52-week range, 11.37% below the high.
CN¥20.22-CN¥0.13 (-0.64%)
Dian Diagnostics Group Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 39.28% below the high.
CN¥5.54-CN¥0.26 (-4.48%)
Zhejiang Hisoar Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 39.05% below the high.
CN¥4.37+CN¥0.12 (+2.82%)
Huapont Life Sciences Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 28.13% below the high.
CN¥15.98-CN¥0.10 (-0.62%)
Guangzhou Wondfo Biotech Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 39.22% below the high.
CN¥19.09-CN¥0.70 (-3.54%)
Amoy Diagnostics Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 20.89% below the high.
CN¥12.46-CN¥0.04 (-0.32%)
Beijing Strong Biotechnologies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 22.37% below the high.
CN¥8.67+CN¥0.12 (+1.4%)
KPC Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 38.29% below the high.
